2m 2m 2m 2m 2m 2m 2m
ORIC PHARMA (ORIC)
NASDAQ
$11.06-$0.02 (-0.14%)
Price as of Aug 03, 2026 6:12 AM EDT- $1.1BMarket Cap
- 9.39%1-Year Change
- BiotechnologyIndustry
ORIC PHARMA (ORIC)
$11.06-$0.02 (-0.14%)
ORIC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.07 | ||
Change | -$0.57 (-4.90%) | ||
Open | $11.67 | ||
High | $11.74 | ||
Low | $10.98 | ||
Previous Close | $11.64 | ||
Volume | 1,238,822 | ||
30-Day Average Volume | 1,651,348 | ||
1-Week Change | -8.51% | ||
1-Month Change | 2.22% | ||
1-Year Change | 9.39% | ||
3-Year Change | 32.42% | ||
5-Year Change | -33.51% | ||
Fundamentals | |||
Shares Outstanding | 103.5M | ||
Total Assets | $436.8M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$35.8M | ||
Free Cash Flow | -$32.4M | ||
EBIT | -$35.8M | ||
EBITDA | -$35.5M | ||
Net Working Capital | $272.5M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -33 | ||
PEG | 2 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue